# Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

> **NCT00736255** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 32 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder
- Nicotine Dependence

## Interventions

- **DRUG:** Transdermal Nicotine Patch
- **DRUG:** Lis-dexamphetamine (Vyvanse)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00736255
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736255, "Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00736255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*